Objective response (partial and complete) [clinicaltrials_resource:5d7e3a3991d32420f6e742b0bf0e2a3a]

Objective response (partial and complete) [clinicaltrials_resource:5d7e3a3991d32420f6e742b0bf0e2a3a]

Clinical trial summary from the National Cancer Institute's PDQ® database
clinicaltrials resource [clinicaltrials_vocabulary:Resource]
Secondary outcome [clinicaltrials_vocabulary:secondary-outcome]
http://bio2rdf.org/clinicaltrials_resource:5d7e3a3991d32420f6e742b0bf0e2a3a
Monoclonal Antibody With or Without gp100 Peptides Plus Montanide ISA-51 in Treating Patients With Stage IV Melanoma [clinicaltrials:NCT00077532]
clinicaltrials_vocabulary:secondary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:secondary-outcome]

Objective response (partial and complete) [clinicaltrials_resource:5d7e3a3991d32420f6e742b0bf0e2a3a]

Clinical trial summary from the National Cancer Institute's PDQ® database
clinicaltrials resource [clinicaltrials_vocabulary:Resource]
Secondary outcome [clinicaltrials_vocabulary:secondary-outcome]
http://bio2rdf.org/clinicaltrials_resource:5d7e3a3991d32420f6e742b0bf0e2a3a
Bio2RDF identifier
5d7e3a3991d32420f6e742b0bf0e2a3a
Bio2RDF namespace
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:5d7e3a3991d32420f6e742b0bf0e2a3a
measure [clinicaltrials_vocabulary:measure]
Objective response (partial and complete)
description
Clinical trial summary from the National Cancer Institute's PDQ® database
identifier
clinicaltrials_resource:5d7e3a3991d32420f6e742b0bf0e2a3a
title
Objective response (partial and complete)
@en
inDataset
type
label
Objective response (partial an ...... e3a3991d32420f6e742b0bf0e2a3a]
@en